Tissue Regenix Group is an international medical technology company specializing in regenerative products using its dCELL® and BioRinse™ platform technologies. These technologies address soft tissue and bone allograft needs through products like DermaPure® for soft tissue repair and ConCelltrate® for bone regeneration, primarily serving the BioSurgery, Orthopaedics, and Dental markets. The company was founded in 2006 in Leeds, UK, and has operations in the UK and US.